Biocon teams up with Sandoz for next-gen Biosimilars Industry-The Economic Times — January 18, 2018 comments off Biosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy.
Biosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy.